Termination of the Symbicort Sales and Co-Promotion Agreement
An event involving the termination of a specific contract whose term was changed, with the agreement for the sale and co-promotion of Symbicort with AstraZeneca ending in July 2019 and contributing to a decline in revenue.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.